Be a Smart Investor
Tuesday, March 29, 2016
Alder Biopharmaceuticals Inc. (ALDR) Jumped On Phase 2 Study Results
Alder Biopharmaceuticals Inc. (ALDR) announced Monday morning that its Phase 2b study of ALD403 met both its primary and secondary efficacy endpoints.
from RTT - Before the Bell http://ift.tt/1pHeOVe
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment